Antibody Drug Conjugates

Overview

SELECTBIO brings to you its 3rd International conference on ADC Development & Manufacture "Antibody Drug Conjugates" on May 24-25, 2018 in Bengaluru, India.

An innovative therapeutic application which combines the distinctive properties of monoclonal antibodies (mAbs) with the potent cytotoxic effect of small drug molecules is Antibody-drug conjugates or ADCs. This conference will be covering different aspects of ADC development and manufacture, right from the introduction to regulatory thereby ensuring comprehensive understanding of the subject. In addition this event will provide an excellent platform for knowledge sharing, collaborative research and networking with the scientists in the field of Antibody Engineering, Antibody drug conjugates, biopharmaceuticals and Cancer research.

This event is co-located with our International Conference Biomarkers- From Research to Commercialization. 

Running alongside the conferences will be an exhibition covering the latest advancements & instrumentations in the related research area.

Venue and Date: Bengaluru, May 24-25, 2018

Sponsorship Options: Companies willing to participate in this event as Sponsors should contact the Exhibition Manager. Sponsorship options with Delegate Participation are also available.